Receptors, Interleukin-8A, antagonists & inhibitors
- Name
- Receptors, Interleukin-8A, antagonists & inhibitors
- Accession Number
- DBCAT003048
- Description
Not Available
- Drugs
Drug Drug Description Navarixin Navarixin has been investigated for the treatment of Asthma. Ladarixin Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual Β-Cell Function). - Drugs & Drug Targets
Drug Target Type